Key facts
- This page summarizes Seth Lederman's Form 4 filing for Tonix Pharmaceuticals Holding Corp. (TNXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 Aug 2026, 08:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Reporting person may be deemed a control person of this entity.